)
Don't want to miss the best from Business Standard?
Indian Drugs and Pharmaceuticals Limited (IDPL), the central public sector enterprises under the Department of Pharmaceuticals, has modernised the general tablet manufacturing section at its Gurgaon plant. IDPL has invested Rs 3 crore for the modernisation of unit, which was inaugurated on August 5, 2015 by Ananth Kumar, Minister of Chemicals & Fertilizers.
After modernisation, IDPL’s Gurgaon plant will be able to launch new products in the field of diabetes, oncology, NSAIDS, antibiotics (third generation), nephrology and cardiology including other segments of lifestyle diseases at affordable prices and will play a vital role in providing the medicines at reasonable rate for the common people.
Ananth Kumar said that his department is working on ‘Make-In-India’ mantra and this unit of IDPL is a step in that direction. Assuring the government’s full support in enhancing the efficiency and productivity of the public sector undertakings (PSUs), Ananth Kumar said that providing affordable and good quality medicines to masses of the country is important and the public sector undertakings have an important role to play as they are not driven by profit motive but also serve public interest.
Also Read
He assured that the PSUs will not be sold. Instead, a model will be developed for leveraging their assets to make them financially sustainable. The Minister said that a task force will be set up soon to look into all these aspects. Ananth Kumar informed that Jan Aushadhi will be revamped, while steps are being taken to set up pharma clusters, pharma parks and medical devices parks in the country.
Dr V K Subburaj, secretary, Department of Pharmaceuticals, said, “Besides affordability and availability, quality of the medicines is also important. The government is taking policy initiatives so that more and more Indian pharmaceutical companies become compliant to the WHO Quality Standards. The drugs provided by IDPL and other PSUs will facilitate in smooth functioning of the government’s programmes and help provide access to people of good quality medicines.”
